🇺🇸 Trazodone HCl in United States

11,031 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 11,031

Most-reported reactions

1. Nausea — 1,427 reports (12.94%)
2. Fatigue — 1,360 reports (12.33%)
3. Headache — 1,248 reports (11.31%)
4. Pain — 1,137 reports (10.31%)
5. Drug Ineffective — 1,085 reports (9.84%)
6. Dyspnoea — 1,041 reports (9.44%)
7. Diarrhoea — 962 reports (8.72%)
8. Dizziness — 950 reports (8.61%)
9. Depression — 925 reports (8.39%)
10. Insomnia — 896 reports (8.12%)

Source database →

Frequently asked questions

Is Trazodone HCl approved in United States?

Trazodone HCl does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Trazodone HCl in United States?

Labopharm Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.